Navigation Links
Allergists find value in social media to educate and connect
Date:11/8/2012

Twitter, a popular social network and microblogging service, is rapidly being adopted by allergists. A study presented at the American College of Allergy, Asthma and Immunology's (ACAAI) Annual Scientific Meeting in Anaheim, Calif. Nov. 8-13 has found there has been a 470 percent increase in allergist use in just one year. Allergists are primarily using Twitter to educate their patients and the public about allergy-related information. They are also connecting with their peers.

Title: Rapid Growth of Twitter Use by Allergists and Immunologists for Professional Purposes

Lead Author: Nana Sarkoah Fenny, M.D.

Co-Author: Allergist Vesselin Dimov, M.D., ACAAI member

By the Numbers: There were 85 self-identified allergists on Twitter in 2012, compared to 18 in 2011. This represents a 470 percent increase in use by allergists in one year. Of these allergists, 80 percent have more than 50 followers, and 78 percent of all allergists followed at least one of their peers. Of the 1,307 tweets analyzed, 49 percent were allergy-related and 52 percent contained hyperlinks.


'/>"/>

Contact: Christine Westendorf
christinewestendorf@acaai.org
847-427-1200
American College of Allergy, Asthma, and Immunology
Source:Eurekalert

Page: 1

Related medicine news :

1. Penn Medicine researchers map strategy for choosing wisely on low-value health care services
2. Discovery of essential genes for drug-resistant bacteria reveals new, high-value drug targets
3. UMass Amherst sleep researchers study value of preschool naps
4. Little Evidence on Value of Treatments for Autism: Report
5. Study questions value of calcium and vitamin D supplements
6. MAK value lowered for chlorinated biphenyls
7. Breast Cancer Charity Overstates Value of Mammograms: Researchers
8. Studies Show Value of AIDS Drugs as Prevention
9. New curriculum teaches internal medicine residents high value, cost-conscious care principles
10. Taking nothing at face value
11. Specialized MRI scans assess value of anti-cancer chemotherapy long before tumors shown to shrink
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... WA (PRWEB) , ... April 24, 2017 , ... ... leading lifestyle brands, work wear distributors and International relief organizations across the globe ... The company also offers lifestyle and work wear collections via insectshield.com . ...
(Date:4/24/2017)... ... , ... A 2-in-1 bottleless water appliance provides both purified ... Texas, here are the ways in which this technology can benefit dental offices: ... fresh, oxygenated water, with both cold and hot options. , Convenience for Dentists ...
(Date:4/23/2017)... (PRWEB) , ... April 23, 2017 , ... ... and managed services announced the achievement of Cisco Select certification and SMB specialization. ... the United States. , In earning the Select Certification, Altura fulfilled ...
(Date:4/22/2017)... Philadelphia, PA (PRWEB) , ... ... ... Small Business Administration of Eastern Pennsylvania has named PROSHRED® Security of ... Pennsylvania-native Ginny Heron-Doerr, PROSHRED® Philadelphia specializes in providing information destruction ...
(Date:4/22/2017)... , ... April 22, 2017 , ... ... his role as Vice President of Sales and Business Development at OAKWORKS, Inc. ... business partner engagements, business development, and strategic planning for the company. Recognized ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
Breaking Medicine Technology: